Cancer Research UK appoints new chief scientist
This article was originally published in Clinica
Prof Nic Jones is to become the new chief scientist at Cancer Research UK, effective 1 February 2011. Prof Jones is currently director of CRUK's Paterson Institute at the University of Manchester – he plans to step down from this role when he takes up his new position, but will continue to lead his research group at the institute, which is studying how cells respond to sudden adverse changes in their surroundings. He will also continue in his current role of director of the Manchester Cancer Research Centre, which brings together key players in cancer research in the city. Prof Jones will succeed Prof Sir David Lane as CRUK's chief scientist. Sir David will continue to advise the charity on its research strategy.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.